UNSPSC 51123107: Dofetilide

This classification denotes a cation channel blocker and antiarrhythmic agent with the molecular formula C19H27N3O5S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) R4Z9X1N2ND, chemically known as uk 68,798 but more generally known as dofetilide, which bears US NIH Compound Identifier 71329. European Medicines Agency schedules Dofetilide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06351MIG.

UNSPSC 51123107 Dofetilide is a Commodity code for a specific cardiac antiarrhythmic pharmaceutical product, but the recent state and local procurement activity under this code does not isolate dofetilide as a line item. Instead, state and local issuing bodies are soliciting emergency medical service medications as aggregated lots that span multiple active pharmaceutical ingredients. The City of Tampa's Purchasing Department, acting on behalf of Tampa Fire Rescue, issued IFB 26P00188 for Advanced Life Support Medications—a sealed-bid procurement requiring four distinct medication products (labetalol, epinephrine, adenosine, and diltiazem) in specified unit quantities, with a combined estimated value of $40,000.00. Vendors must meet firm pricing inclusive of freight to Tampa, Florida; warrant medications free from defects for a minimum of 365 days; and guarantee an expiration date of nine months or more from acceptance, with pickup and replacement of expired stock before expiration. The City designated the opportunity as a Small Local Business Enterprise sheltered market with a 5 percent SLBE bid discount not to exceed $10,000. The contract term runs one year from award, renewable by mutual agreement for two additional one-year periods, plus unilateral extension options for up to three additional 30-day periods at the same terms.

The code shows limited transparent single-jurisdiction activity. The Tampa Fire Rescue procurement represents the primary recent visible opportunity in the dataset, posted in April 2026 with a response deadline of April 8, 2026. The solicitation requires vendors to submit Safety Data Sheets compliant with OSHA Hazard Communication Standards and accessibility documentation including a Voluntary Product Accessibility Template conforming to WCAG 2.2 Level AA and Section 508 standards. Award will be made to the lowest responsive, responsible bidder within 120 days of bid opening. Beyond the Tampa opportunity, the source provides no additional recent state or local solicitations under this Commodity code, suggesting either narrow utilization of dofetilide as a standalone pharmaceutical line item in public procurement or classification variance across issuing bodies that obscures activity under the specific code.